Clinical Trials Browser

Withdrawn × Precursor Cell Lymphoblastic Leukemia-Lymphoma × ibrutinib × Clear all

NCT02815059 2018-01-31

Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma